North America Cervical Cancer Test Market, Volume & Mortality - PowerPoint PPT Presentation

Loading...

PPT – North America Cervical Cancer Test Market, Volume & Mortality PowerPoint presentation | free to download - id: 867aea-NTg1N



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

North America Cervical Cancer Test Market, Volume & Mortality

Description:

Cervical cancer is one of the most common causes of cancer death for North American women. It is estimated that over 4,000 women in the United States and 400 women in Canada die from cervical cancer in 2016. However, it is also one of the most preventable types of cancer. Pap smear and HPV DNA test are two most popular testing methods to diagnose cervical cancer cases in North America. United States is the leader in North America cervical cancer test market. It holds over 90 percent testing population share alone, and is likely to maintain its position in forecasting period as well due to women getting regular Pap tests. Download full Report: – PowerPoint PPT presentation

Number of Views:17

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: North America Cervical Cancer Test Market, Volume & Mortality


1
(No Transcript)
2
Canada, United States Cervical Cancer Screening
Market Patients, By Test Type (Pap Smear HPV
DNA VIA) in North America
Cervical Cancer Screening Market in North
America Table of Contents 1. Executive
Summary 2. North America Cervical Cancer Test
(Screening) Population Forecast 3. North
America Cervical Cancer Test (Screening) Market
Forecast 3.1 North America Cervical Cancer Pap
Smear Test (Screening) Market
Forecast 3.2 North America Cervical Cancer HPV
DNA Test (Screening) Market Forecast 4. North
America Cervical Cancer Test (Screening)
Population Share, Market Share Forecast

3
Continue (www.renub.com)
4.1 North America Cervical Cancer Test
(Screening) Population Share Forecast 4.2 North
America Cervical Cancer Test (Screening) Market
Share Forecast 4.3 North America Cervical
Cancer Pap Smear Test (Screening) Market Share
Forecast 4.4 North America Cervical Cancer HPV
DNA Test (Screening) Market Share
Forecast 5. United States Cervical Cancer Test
Analysis 5.1 United States Cervical Cancer Test
(Screening) Population 5.1.1 United States
Cervical Cancer Pap Smear Test Population
Forecast 5.1.2 United States Cervical Cancer HPV
DNA Test Population Forecast 5.2 United States
Cervical Cancer Mortality 5.3 United States
Cervical Cancer Test (Screening)
Market 5.3.1 United States Cervical Cancer Test
Market Forecast

4
Continue (www.renub.com)
5.3.2 United States Pap smear Test Market
Forecast 5.3.3 United States HPV DNA Test Market
Forecast 6. Canada Cervical Cancer Test
Analysis 6.1 Canada Cervical Cancer Test
(Screening) Population 6.1.1 Canada Cervical
Cancer Pap Smear Test Population
Forecast 6.1.2 Canada Cervical Cancer HPV DNA
Test Population Forecast 6.2 Canada Cervical
Cancer Mortality 6.3 Canada Cervical Cancer Test
(Screening) Market 6.3.1 Canada Cervical Cancer
Test Market Forecast 6.3.2 Canada Pap Smear
Test Market Forecast 6.3.3 Canada HPV DNA Test
Market Forecast 7. Cervical Cancer Test Market
Growth Drivers 7.1 Worldwide Rising Incidence of
Teenage Sexual Cases 7.2 Worldwide High
Prevalence of HPV Infected Patients

5
Continue (www.renub.com)
Countries Covered in this Report
  • 8. Challenges in Cervical Cancer Test Market
  • 8.1 Increase HPV Vaccination
  • Download full Report
  • http//www.renub.com/canada-united-states-cervical
    -cancer-screening-market-and-patients-by-test-type
    -pap-smear-hpv-dna-via-in-north-america-997-p.php
  •  
  • Medical Devices Report
  • http//www.renub.com/diagnostics-14-c.php


6
Continue (www.renub.com)
  • Renub Research - North America
  • Rajat Gupta
  • 225 Kristie Ln, Roswell
  • Georgia 30076, United States
  • Tel 1-678-302-0700
  • Email info_at_renub.com
  • www.renub.com
  •  

About PowerShow.com